MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 17.02.2026
CONMED Corporation Kurzfristige Verbindlichkeiten 2011-2026 | CNMD
Kurzfristige Verbindlichkeiten Jährlich CONMED Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 315 M | 278 M | 311 M | 297 M | 197 M | 190 M | 188 M | 161 M | 150 M | 114 M | 120 M | 116 M | 111 M | 123 M | 131 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 315 M | 111 M | 187 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
1.9 M | $ 2.2 | -0.9 % | $ 3.43 M |  USA |
 |
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
712 M | $ 10.52 | 0.67 % | $ 1.42 B | USA |
 |
ClearPoint Neuro
CLPT
|
10.8 M | $ 9.61 | -13.89 % | $ 272 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
219 M | $ 12.68 | -2.87 % | $ 1.9 B | USA |
 |
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.66 | -3.66 % | $ 35.9 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
219 M | $ 8.32 | -0.42 % | $ 597 M |  Israel |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
48.2 M | $ 4.0 | -6.44 % | $ 847 M | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.44 B | $ 71.61 | 0.58 % | $ 106 B | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | $ 3.9 | -3.94 % | $ 145 M |  France |
 |
Establishment Labs Holdings
ESTA
|
82.1 M | $ 64.89 | -0.18 % | $ 1.92 B |  Costa-rica |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | USA |
 |
InMode Ltd.
INMD
|
70.7 M | $ 13.45 | -1.47 % | $ 869 M | Israel |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 16.7 | -2.96 % | $ 392 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
FONAR Corporation
FONR
|
16.7 M | $ 18.44 | -0.05 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
Abbott Laboratories
ABT
|
16.5 B | $ 108.09 | -2.37 % | $ 188 B | USA |
 |
IRIDEX Corporation
IRIX
|
13 M | $ 1.33 | 0.01 % | $ 21.5 M | USA |
 |
Delcath Systems
DCTH
|
11 M | $ 9.4 | -3.49 % | $ 337 M | USA |
 |
Bio-Rad Laboratories
BIO
|
468 M | $ 269.56 | 0.03 % | $ 7.61 B | USA |
 |
Myomo
MYO
|
8.35 M | $ 0.71 | -1.55 % | $ 29.7 M | USA |
 |
Helius Medical Technologies
HSDT
|
1.88 M | $ 2.08 | -4.38 % | $ 1.26 M | USA |
 |
AxoGen
AXGN
|
23.6 M | $ 31.04 | -5.22 % | $ 1.43 B | USA |
 |
Align Technology
ALGN
|
2.04 B | $ 172.44 | -2.09 % | $ 12.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
922 M | $ 8.85 | -2.8 % | $ 682 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 34.33 | 1.75 % | $ 5.12 K | USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
11.7 M | $ 3.69 | -1.47 % | $ 152 M | USA |
 |
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
193 M | $ 0.41 | 4.42 % | $ 42.1 M | USA |